Insider · CIK 0001550642

Venkataraman Sriram

Reports to the SEC for 5 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001550642

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-27	RVL Pharmaceuticals plcJ Other	Director, 10% Owner	JOther	−1.03M sh	—	—	0
2022-08-08	RVL Pharmaceuticals plcP Purchase	Director, 10% Owner	PPurchase	+8M sh	$1.55	+$12.4M	23,730,864
2020-11-20	RVL Pharmaceuticals plcJ Other	Director, 10% Owner	JOther	−4.94M sh	—	—	0
2020-06-10	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+14.4K sh	$5.65	+$81.6K	14,439
2020-01-13	RVL Pharmaceuticals plcP Purchase	Director, 10% Owner	PPurchase	+1.25M sh	$5.00	+$6.25M	15,730,864
2019-11-25	OptiNose, Inc.S Sale	Director, 10% Owner	SSale	−888K sh	$9.16	−$8.14M	10,136,374
2019-11-25	OptiNose, Inc.S Sale	Director, 10% Owner	SSale	−292K sh	$9.16	−$2.67M	3,328,648
2019-11-25	OptiNose, Inc.S Sale	Director, 10% Owner	SSale	−70.8K sh	$9.16	−$649K	807,995
2019-06-06	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+14.4K sh	$6.60	+$95.3K	14,439
2018-06-11	OptiNose, Inc.S Sale	Director, 10% Owner	SSale	−2.04M sh	$20.91	−$42.7M	11,024,096
2018-06-11	OptiNose, Inc.S Sale	Director, 10% Owner	SSale	−670K sh	$20.91	−$14M	3,620,164
2018-06-11	OptiNose, Inc.S Sale	Director, 10% Owner	SSale	−163K sh	$20.91	−$3.4M	878,757
2018-06-07	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+14.4K sh	$22.50	+$325K	14,439
2017-10-17	OptiNose, Inc.A Award	Director, 10% Owner	AAward	+888K sh	$16.00	+$14.2M	988,292
2017-10-17	OptiNose, Inc.A Award	Director, 10% Owner	AAward	+292K sh	$16.00	+$4.66M	4,290,651
2017-10-17	OptiNose, Inc.A Award	Director, 10% Owner	AAward	+70.8K sh	$16.00	+$1.13M	1,041,511
2017-10-17	OptiNose, Inc.C Conversion	Director, 10% Owner	CConversion	+12.1M sh	—	—	13,065,855
2017-10-17	OptiNose, Inc.C Conversion	Director, 10% Owner	CConversion	+3.97M sh	—	—	4,290,651
2017-10-17	OptiNose, Inc.C Conversion	Director, 10% Owner	CConversion	+963K sh	—	—	1,041,511
2017-10-17	OptiNose, Inc.Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.79M sh	—	—	0
2017-10-17	OptiNose, Inc.Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−915K sh	—	—	0
2017-10-17	OptiNose, Inc.Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−222K sh	—	—	0
2017-10-17	OptiNose, Inc.Series C-1 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−825K sh	—	—	0
2017-10-17	OptiNose, Inc.Series C-1 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−271K sh	—	—	0
2017-10-17	OptiNose, Inc.Series C-1 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−65.8K sh	—	—	0
2017-10-17	OptiNose, Inc.Series C-2 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−355K sh	—	—	0
2017-10-17	OptiNose, Inc.Series C-2 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−117K sh	—	—	0
2017-10-17	OptiNose, Inc.Series C-2 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−28.3K sh	—	—	0
2017-10-17	OptiNose, Inc.Series D Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−216K sh	—	—	0
2017-10-17	OptiNose, Inc.Series D Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−216K sh	—	—	0
2017-10-17	OptiNose, Inc.Series D Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−17.2K sh	—	—	0
2017-03-17	LNTHLantheus Holdings, Inc.S Sale	Director, 10% Owner	SSale	−1.71M sh	$12.20	−$20.9M	7,004,395
2017-03-17	LNTHLantheus Holdings, Inc.S Sale	Director, 10% Owner	SSale	−451K sh	$12.20	−$5.5M	1,846,996
2017-03-17	LNTHLantheus Holdings, Inc.S Sale	Director, 10% Owner	SSale	−840K sh	$12.20	−$10.2M	3,442,208
2016-11-21	LNTHLantheus Holdings, Inc.S Sale	Director, 10% Owner	SSale	−1.42M sh	$9.00	−$12.8M	8,713,673
2016-11-21	LNTHLantheus Holdings, Inc.S Sale	Director, 10% Owner	SSale	−376K sh	$9.00	−$3.38M	2,297,718
2016-11-21	LNTHLantheus Holdings, Inc.S Sale	Director, 10% Owner	SSale	−700K sh	$9.00	−$6.3M	4,282,208

Recent filings

Accepted (ET)
Jan 304
Venkataraman Sriram0001104659-23-008077
SEC(opens sec.gov)
Aug 94
Venkataraman Sriram0001104659-22-088030
SEC(opens sec.gov)
Nov 234
Venkataraman Sriram0001104659-20-128528
SEC(opens sec.gov)
Jun 124
Venkataraman Sriram0001494650-20-000071
SEC(opens sec.gov)
Jan 154
Venkataraman Sriram0001104659-20-004324
SEC(opens sec.gov)
Nov 264
Venkataraman Sriram0000899243-19-028170
SEC(opens sec.gov)
Jun 104
Venkataraman Sriram0001494650-19-000057
SEC(opens sec.gov)
Jun 134
Venkataraman Sriram0000899243-18-016384
SEC(opens sec.gov)
Jun 114
Venkataraman Sriram0001494650-18-000068
SEC(opens sec.gov)
Oct 194
Venkataraman Sriram0000899243-17-024502
SEC(opens sec.gov)

Companies

Address

C/O AVISTA CAPITAL PARTNERS 65 E. 55TH STREET, 18TH FLOOR

NEW YORK, NY, 10022